CLIMACTERIC – transition from
____________ to ______________ state
reproductive to non-reproductive
MENOPAUSE – _____________________
of _____________ . Usually diagnosed
after ________ of _____________.
permanent ceasation
menstruation
1 year; amenorrhoea
The average age at menopause in
Nigeria is ______ ± 1.5 years.
In western women, the average age at menopause is ______ years.
49
52
Menopause occuring before the age of 45 is termed “ ____________________________”
.
PREMATURE MENOPAUSE
PATHOPHYSIOLOGY of menopause
Human ovary contains an outer ————- and an inner ___________ .
Both contains ___________ cells which provide support for the ovary, produce steroids (basically
___________) and some are recruited to become ___________ cells that surround ___________ in the cortex.
For every ___________ which matures to ovulation, up to _________m follicles fail and become ___________ while probably only about 400 out of the 400,000 follicles present at puberty mature to ovulation
Cortex ; medulla.
stroma ; androgens
theca ; follicles
follicle ; 1000 follicles
atretic
PATHOPHYSIOLOGY of menopause
With ageing, the ___________ diminishes and finally the ___________ fail.
The first endocrine change as menopause approaches is a fall in the ___________ level. The function of this hormone is to _________________ . Hence FSH level ________ .
Oestradiol level subsequently _________ and become insufficient to bring about endometrial ___________ and menstruation
follicle count ; ovaries
inhibin ; inhibit FSH production.
rises ; falls
proliferation
The first endocrine change as menopause approaches is a fall in the ___________ level.
Inhibin
PATHOPHYSIOLOGY of menopause
The ovaries produce four principal
hormones: __________ , __________
and the __________ (__________
and __________). It also
secretes the peptide hormone
“__________”
oestradiol ; progesterone
androgens ; testosterone
androstenedione ; Inhibin
Ovarian cycle and menstrual
function are controlled by _______ and ______ release
FSH
LH
PATHOPHYSIOLOGY
In premenopausal state, majority of the circulating plasma oestradiol is produced by the __________ cells lining the developing __________, by conversion of __________
and __________, and catalysed by the
__________ enzyme, stimulated by ________.
Oestradiol is also converted in the ________ cells from androgens, which are produce from __________ under stimulation of ________.
granulosa ; follicles
androstenedione ; testosterone,
aromatase ; FSH.
theca ; cholesterol
LH.
NON-PHYSIOLOGICAL CAUSES
OF MENOPAUSE
Primary causes – may be due to
chromosomal abnormalities
such as variants of ________________ and autoimmune disorders such as
________________, ________________
disease.
turner’s syndrome
hypothyroidism
Addison’s disease.
NON-PHYSIOLOGICAL CAUSES
OF MENOPAUSE
Secondary causes – can follow
surgeries such as _____________
with _____________ for malignancies or severe endometriosis, radiotherapy, chemotherapy, use of drugs such _____________ in treating conditions like uterine fibroids and
endometriosis, and infections such
as tuberculosis, mumps.
hysterectomy ; bilateral salpingo-
oophorectomy
GnRH analogues
EFFECTS OF MENOPAUSE
VASOMOTOR SYMPTOMS
List 3
Hot flushes.
Night sweats.
Palpitations.
EFFECTS OF MENOPAUSE
UROGENITAL
Vulval and vaginal ————- .
Recurrent ___________ .
Sensory urgency.
Urogenital ___________ .
______________.
Decreased _______________.
dryness
urinary tract infections
prolapse; Dyspareunia
sexual desire
EFFECTS OF MENOPAUSE
MUSCULOSKELETAL
___________ .
___________ with resultant pathological fractures
Arthritis
Osteoporosis
EFFECTS OF MENOPAUSE
PSYCHOSEXUAL
Insomnia.
Anxiety.
_____________.
Forgetfulness (__________).
_____________ .
Difficulty in concentration.
Decreased sexual desire.
Low esteem
Dementia
Depression
EFFECTS OF MENOPAUSE
CARDIOVASCULAR
Cardiovascular diseases such as
__________________.
cardiac ischaemia
EFFECTS OF MENOPAUSE
OTHERS
Skin ____________, dryness and itchiness.
________ changes.
wrinkling
Hair
CLINICAL EVALUATION OF A
PERIMENOPAUSAL OR POST-
MENOPAUSAL WOMAN
HISTORY
Age
__________ of amenorrhoea.
Enquire about menopausal symptoms, their _________,________, and __________ on day-to-day activities.
Previous __________ and __________.
Personal and family history to assess the risk for cardiovascular disease, thrombosis, osteoporosis, breast cancer and ovarian
Duration ; frequency
severity ; impact
treatments ; side effects
CLINICAL EVALUATION OF A
PERIMENOPAUSAL OR POST-
MENOPAUSAL WOMAN
EXAMINATION
Assessment of cardiovascular system
– PR, BP, heart sounds.
Check for ______________________.
Pelvic examination – check for vulva
and vaginal ____________ changes.
thyroid enlargement
atrophic
CLINICAL EVALUATION OF A
PERIMENOPAUSAL OR POST-
MENOPAUSAL WOMAN
INVESTIGATIONS
________ >30IU/L is diagnostic.
Investigations to rule out secondary
causes e.g._______ to rule out
___________ , 24-hour urinary
______________ level (VMA) to rule out _______________
FSH
TFT; hypothyroidism
catecholamine; phaechromocytoma
MANAGEMENT
Alternative therapy – use of _____________ , herbal preparations like _______________ , acupuncture,
magnetism, reflexology.
phyto-oestrogens
St. John’s Wort
MANAGEMENT
Medical treatments –
NON-HORMONAL
1. α-adrenergic e.g. clonodine.
2. β-blockers e.g. propanolol.
3. Selective serotonin reuptake inhibitors (SSRI) e.g.
venlafaxine, fluoxetine, Gabapentin.
4. Selective Estrogen Receptor Modulator (SERM)
e.g. Raloxifene.
5.Tibolone – has oestrogenic, progesteronic and androgenic properties. If given for 1 year, will
effectively reduce climacteric symptoms and reduce bone loss.
Cute
MANAGEMENT
Medical treatments –
HORMONAL
1. HRT – can be ___________________ ,
___________________, ___________________. This
helps in reducing ____________.
oestrogen alone
oestrogen + progesterone combined
progesterone alone
hot flushes.